Rankings
▼
Calendar
AMRN
Amarin Corporation plc
$338M
Q3 2017 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$47M
+44.7% YoY
Gross Profit
$35M
74.8% margin
Operating Income
-$8M
-17.8% margin
Net Income
-$11M
-22.9% margin
EPS (Diluted)
$-0.80
QoQ Revenue Growth
+4.7%
Cash Flow
Operating Cash Flow
-$6M
Free Cash Flow
-$6M
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$167M
Total Liabilities
$213M
Stockholders' Equity
-$46M
Cash & Equivalents
$79M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$47M
$33M
+44.7%
Gross Profit
$35M
$24M
+45.9%
Operating Income
-$8M
-$15M
+44.7%
Net Income
-$11M
-$16M
+31.4%
← FY 2017
All Quarters
Q4 2017 →
AMRN Q3 2017 Earnings — Amarin Corporation plc Revenue & Financial Results | Market Cap Arena